Default company panoramic image

CivaTech Oncology

Civatech is developing novel, polymer based brachytherapy devices. Our first product, the CivaString, has been granted FDA 510k clearance.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Durham, NC, USA
  • Currency USD
  • Founded April 2006
  • Website

Company Summary

Civatech Oncology is an emerging medical device company focusing on the development of novel polymer based devices that treat cancer using localized, low-dose-rate radiation.

CivaTech's patented polymer technology enables devices that can be designed and fabricated for specific tumor types. The Company is initially targeting breast, prostate and lung cancer. The approved product is a linear source that meets existing reimbursement codes.


  • Default avatar
    Suzanne Troxler Babcock
    Executive Chair

  • Default avatar
    Seth A. Hoedl Ph.D
    Director of Research and CSO


  • Default avatar
    Merrill Mason, Smith Anderson Blount & Dorsett